Directa Plus PLC (AIM:DCTA, OTC:DTPKF) has received authorisation from the United States Environment Protection Agency (EPA) for its Grafysorber technology to be used in oil contamination treatment.
The producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets said the authorisation confirms that Grafysorber fully meets the EPA's legal requirements and can be used at any oil spill on US territory.
Directa Plus's patented Grafysorber technology is a graphene-based solution for treating water sludges and emulsions containing hydrocarbons and is at least five times more effective than current technologies, the company said. In addition, Grafysorber is sustainably produced, non-flammable and reusable, with the adsorbed hydrocarbons recoverable.
"The EPA approval is the vital first step towards entering the very large US oil decontamination market. We believe that the benefits of using Grafysorber compared with competing products will generate significant interest from the US decontamination companies we can now start approaching,” said Giulio Cesareo, the founder and chief executive officer of Directa Plus.
“We have always expected that this patented technology would have considerable export potential and this authorisation allows us to begin to realise that potential. In addition, we expect to shortly be able to announce the first order of Grafysorber from a UK company," he added.